Wells Fargo & Company »

Lyell Immunopharma shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.8k 125 30.78
2025-06-30 $17k 2.0k 8.84

More positions owned by Wells Fargo & Company

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom Put Option (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon Call Option (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Put Option (META)

View all positions for Wells Fargo & Company

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Vanguard Group
Foresite Capital Management IV
Orland Properties
Almitas Capital
Foresite Capital Management V
Citadel Advisors
venBio Partners
Alphabet
BlackRock
Geode Capital Management
Susquehanna International
Sc China Holding
Millennium Management

View all funds holding Lyell Immunopharma